Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act

Summary

Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act This bill addresses prescription drugs and extends several health care, research, and workforce programs. Currently, a generic drug manufacturer is awarded 180 days of exclusivity on the market if it is the first applicant to file an application with the Food and Drug Administration (FDA), and the exclusivity period begins upon the first applicant's commercial marketing. The bill authorizes the FDA to approve a subsequent generic drug application prior to the first applicant's first date of commercial marketing if certain conditions are met. The bill prohibits a brand-name, generic, or biosimilar drug manufacturer from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement, with specified exclusions, is a violation of the bill if the filer of the subsequent generic application receives something of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biological product. The developer of a drug or biological product, such as a generic or biosimilar version of a drug, may bring a civil action against the license holder of an approved drug if the holder has declined to make available sufficient quantities of the approved drug for the developer's testing. The bill also extends several health care, research, and workforce programs, including the National Health Service Corps, through FY2020.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 14 May 2019

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 14 May 2019

   Introduced

   Introduced in House

   Source: IntroReferral

3. 14 May 2019

   Introduced

   Introduced in House

   Source: IntroReferral

4. 15 May 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 26 June 2019

   Referred

   Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 14 May 2019 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 14 May 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 14 May 2019

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 14 May 2019

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Burgess, Michael C. [R-TX-26] · R · Sponsor
• Rep. Walden, Greg [R-OR-2] · R · Sponsor
• Rep. Upton, Fred [R-MI-6] · R · Sponsor
• Rep. McKinley, David B. [R-WV-1] · R · Sponsor
• Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Sponsor
• Rep. Bucshon, Larry [R-IN-8] · R · Sponsor
• Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
• Sen. Mullin, Markwayne [R-OK] · R · Sponsor
• Rep. McMorris Rodgers, Cathy [R-WA-5] · R · Sponsor
• Rep. Long, Billy [R-MO-7] · R · Sponsor
• Rep. Flores, Bill [R-TX-17] · R · Sponsor
• Rep. Hudson, Richard [R-NC-8] · R · Sponsor
• Rep. Shimkus, John [R-IL-15] · R · Sponsor
• Rep. Walberg, Tim [R-MI-5] · R · Sponsor
• Rep. Kinzinger, Adam [R-IL-16] · R · Sponsor
• Rep. Olson, Pete [R-TX-22] · R · Sponsor
• Rep. Johnson, Bill [R-OH-6] · R · Sponsor
• Rep. Guthrie, Brett [R-KY-2] · R · Sponsor
• Rep. Griffith, H. Morgan [R-VA-9] · R · Sponsor
• Rep. Duncan, Jeff [R-SC-3] · R · Sponsor
• Rep. Brooks, Susan W. [R-IN-5] · R · Sponsor
• Rep. Gianforte, Greg [R-MT-At Large] · R · Sponsor
• Rep. Latta, Robert E. [R-OH-5] · R · Sponsor
• Rep. Scalise, Steve [R-LA-1] · R · Sponsor
• Rep. Sensenbrenner, F. James, Jr. [R-WI-5] · R · Sponsor
• Rep. Collins, Doug [R-GA-9] · R · Sponsor
• Rep. Stivers, Steve [R-OH-15] · R · Sponsor
• Rep. Hill, J. French [R-AR-2] · R · Sponsor
• Rep. Mitchell, Paul [R-MI-10] · R · Sponsor
• Rep. Hurd, Will [R-TX-23] · R · Sponsor
• Sen. Marshall, Roger [R-KS] · R · Cosponsor
• Rep. Stefanik, Elise M. [R-NY-21] · R · Cosponsor
• Rep. Loudermilk, Barry [R-GA-11] · R · Cosponsor
• Jim Hagedorn · R · Cosponsor
• Rep. Diaz-Balart, Mario [R-FL-26] · R · Cosponsor
• Rep. Herrera Beutler, Jaime [R-WA-3] · R · Cosponsor
• Rep. Roe, David P. [R-TN-1] · R · Cosponsor
• Rep. Wittman, Robert J. [R-VA-1] · R · Cosponsor
• Rep. Bost, Mike [R-IL-12] · R · Cosponsor
• Rep. Meadows, Mark [R-NC-11] · R · Cosponsor
• Rep. Joyce, David P. [R-OH-14] · R · Cosponsor
• Rep. Amodei, Mark E. [R-NV-2] · R · Cosponsor
• Rep. Wagner, Ann [R-MO-2] · R · Cosponsor
• Rep. Hartzler, Vicky [R-MO-4] · R · Cosponsor
• Rep. Bishop, Dan [R-NC-8] · R · Cosponsor
• · hsju00 · Standing
• · hsif00 · Standing

Related records

• related to → Lower Costs, More Cures Act of 2019
• related to → Strengthening Health Care and Lowering Prescription Drug Costs Act
• related to → Community and Public Health Programs Extension Act
• related to → CREATES Act of 2019
• related to → BLOCKING Act of 2019
• related to → CREATES Act of 2019
• related to → Protecting Consumer Access to Generic Drugs Act of 2019
• related to → Community Health Center and Primary Care Workforce Expansion Act of 2019
• related to ← PREP Reauthorization Act of 2019

Showing 9 of 11 related records.